Immunocore Holdings (IMCR) Assets Average (2020 - 2026)

Immunocore Holdings (IMCR) has reported Assets Average for 5 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• Quarterly Assets Average rose 5.0% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 5.0% YoY) and the FY2025 annual result came in at $1.0 billion, up 29.27% from the prior year.
• Assets Average declined to $1.1 billion in Q1 2026 per IMCR's latest filing, from $1.1 billion in the prior quarter.
• Over the last five years, Assets Average for IMCR reached as high as $1.1 billion in Q3 2025 and fell as low as $517.5 million in Q4 2022.
• A 4-year average of $974.4 million and a median of $1.1 billion in 2024 frame the typical range for Assets Average.
• The largest YoY upside for Assets Average was 28.07% in 2025 against a maximum downside of 3.61% in 2025.
• Year by year, Assets Average stood at $517.5 million in 2022, then surged by 102.35% to $1.0 billion in 2024, then increased by 3.61% to $1.1 billion in 2025, then dropped by 1.4% to $1.1 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.